Saudi Chemical Holding Company

SASE:2230 Rapporto sulle azioni

Cap. di mercato: ر.س9.9b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Saudi Chemical Holding Performance dei guadagni passati

Il passato criteri di controllo 5/6

Saudi Chemical Holding ha registrato una crescita degli utili a un tasso medio annuo di 30.2%, mentre il settore Healthcare ha registrato utili in crescita a un tasso medio annuo di 18.7%. I ricavi sono stati in crescita a un tasso medio annuo di 12%. Il ritorno sul capitale proprio di Saudi Chemical Holding è 14.7% e ha margini netti di 4.9%.

Informazioni chiave

30.2%

Tasso di crescita degli utili

30.2%

Tasso di crescita dell'EPS

Healthcare Crescita del settore12.3%
Tasso di crescita dei ricavi12.0%
Rendimento del capitale proprio14.7%
Margine netto4.9%
Ultimo aggiornamento sui guadagni30 Jun 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Saudi Chemical Holding Company's (TADAWUL:2230) P/E Is On The Mark

May 28
Saudi Chemical Holding Company's (TADAWUL:2230) P/E Is On The Mark

Investors Met With Slowing Returns on Capital At Saudi Chemical Holding (TADAWUL:2230)

May 07
Investors Met With Slowing Returns on Capital At Saudi Chemical Holding (TADAWUL:2230)

With EPS Growth And More, Saudi Chemical Holding (TADAWUL:2230) Makes An Interesting Case

Mar 06
With EPS Growth And More, Saudi Chemical Holding (TADAWUL:2230) Makes An Interesting Case

Saudi Chemical Holding Company's (TADAWUL:2230) 26% Jump Shows Its Popularity With Investors

Feb 10
Saudi Chemical Holding Company's (TADAWUL:2230) 26% Jump Shows Its Popularity With Investors

Saudi Chemical Holding (TADAWUL:2230) Is Reinvesting At Lower Rates Of Return

Oct 31
Saudi Chemical Holding (TADAWUL:2230) Is Reinvesting At Lower Rates Of Return

Here's Why We Think Saudi Chemical Holding (TADAWUL:2230) Might Deserve Your Attention Today

Jul 06
Here's Why We Think Saudi Chemical Holding (TADAWUL:2230) Might Deserve Your Attention Today

Saudi Chemical Holding (TADAWUL:2230) Is Due To Pay A Dividend Of SAR0.50

Jan 09
Saudi Chemical Holding (TADAWUL:2230) Is Due To Pay A Dividend Of SAR0.50

Saudi Chemical Holding (TADAWUL:2230) Has Affirmed Its Dividend Of SAR0.50

Dec 22
Saudi Chemical Holding (TADAWUL:2230) Has Affirmed Its Dividend Of SAR0.50

Here's What's Concerning About Saudi Chemical Holding's (TADAWUL:2230) Returns On Capital

Sep 14
Here's What's Concerning About Saudi Chemical Holding's (TADAWUL:2230) Returns On Capital

Saudi Chemical Holding (TADAWUL:2230) Will Be Hoping To Turn Its Returns On Capital Around

Dec 06
Saudi Chemical Holding (TADAWUL:2230) Will Be Hoping To Turn Its Returns On Capital Around

Does It Make Sense To Buy Saudi Chemical Holding Company (TADAWUL:2230) For Its Yield?

Apr 19
Does It Make Sense To Buy Saudi Chemical Holding Company (TADAWUL:2230) For Its Yield?

Here's What's Concerning About Saudi Chemical's (TADAWUL:2230) Returns On Capital

Mar 29
Here's What's Concerning About Saudi Chemical's (TADAWUL:2230) Returns On Capital

Is Saudi Chemical Company's (TADAWUL:2230) 2.8% ROE Worse Than Average?

Mar 01
Is Saudi Chemical Company's (TADAWUL:2230) 2.8% ROE Worse Than Average?

Does Saudi Chemical's (TADAWUL:2230) Share Price Gain of 41% Match Its Business Performance?

Feb 01
Does Saudi Chemical's (TADAWUL:2230) Share Price Gain of 41% Match Its Business Performance?

How Has Saudi Chemical (TADAWUL:2230) Allocated Its Capital?

Dec 28
How Has Saudi Chemical (TADAWUL:2230) Allocated Its Capital?

Should You Be Concerned About Saudi Chemical Company's (TADAWUL:2230) ROE?

Nov 30
Should You Be Concerned About Saudi Chemical Company's (TADAWUL:2230) ROE?

Ripartizione dei ricavi e delle spese

Come Saudi Chemical Holding guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

SASE:2230 Ricavi, spese e utili (SAR Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Jun 245,8692883700
31 Mar 245,4602423680
31 Dec 234,8551833560
30 Sep 234,5211173570
30 Jun 234,081933360
31 Mar 233,831803220
31 Dec 223,696803100
30 Sep 223,378512950
30 Jun 223,402482850
31 Mar 223,346612920
31 Dec 213,411702900
30 Sep 213,491532640
30 Jun 213,517642700
31 Mar 213,476772590
31 Dec 203,306742670
30 Sep 203,066463280
30 Jun 202,991413400
31 Mar 202,909323420
31 Dec 192,949333340
30 Sep 193,2261013010
30 Jun 193,1201012800
31 Mar 192,998982630
31 Dec 182,9491152450
30 Sep 182,7681282200
30 Jun 182,6501432110
31 Mar 182,5411432090
31 Dec 172,4741422110
30 Sep 172,2741291960
30 Jun 172,2061191960
31 Mar 172,2791381970
31 Dec 162,1431341940
30 Sep 162,2581682120
30 Jun 162,3031852100
31 Mar 162,3202162100
31 Dec 152,4102512070
30 Sep 152,4132661900
30 Jun 152,4522701960
31 Mar 152,4702791870
31 Dec 142,4842841860
30 Sep 142,5662921890
30 Jun 142,4503131720
31 Mar 142,3593031690
31 Dec 132,2753011630
30 Sep 132,2362921620

Guadagni di qualità: 2230 ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di 2230 (4.9%) 2230 sono più alti rispetto allo scorso anno (2.3%).


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di 2230 sono cresciuti in modo significativo del 30.2% all'anno negli ultimi 5 anni.

Accelerare la crescita: La crescita degli utili di 2230 nell'ultimo anno ( 211.6% ) supera la media quinquennale ( 30.2% all'anno).

Guadagni vs Settore: La crescita degli utili 2230 nell'ultimo anno ( 211.6% ) ha superato la percentuale del settore Healthcare 42.3%.


Rendimento del capitale proprio

ROE elevato: Il Return on Equity ( 14.7% ) di 2230 è considerato basso.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate